A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia. (Q34170309)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia. |
scientific article |
Statements
A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia (English)
Leyuan Ma
Yi Shan
Robert Bai
Liting Xue
Christopher A Eide
Lihua J Zhu
Lloyd Hutchinson
Jan Cerny
Hanna Jean Khoury
Zhi Sheng
Shaoguang Li
Michael R Green
1 September 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference